
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs5.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500002B80DE1D5C46.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="molvis" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3062522/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062522/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Molecular Vision" /><meta name="citation_title" content="Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model" /><meta name="citation_author" content="A. Pauly" /><meta name="citation_author_institution" content="INSERM, UMR_S968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="CNRS, UMR_7210, Paris, France" /><meta name="citation_author" content="E. Brasnu" /><meta name="citation_author_institution" content="INSERM, UMR_S968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="CNRS, UMR_7210, Paris, France" /><meta name="citation_author_institution" content="Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France" /><meta name="citation_author" content="L. Riancho" /><meta name="citation_author_institution" content="INSERM, UMR_S968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="CNRS, UMR_7210, Paris, France" /><meta name="citation_author" content="F. Brignole-Baudouin" /><meta name="citation_author_institution" content="INSERM, UMR_S968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="CNRS, UMR_7210, Paris, France" /><meta name="citation_author_institution" content="Department of Toxicology, Faculty of Biological and Pharmacological Sciences, Paris, France" /><meta name="citation_author" content="C. Baudouin" /><meta name="citation_author_institution" content="INSERM, UMR_S968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France" /><meta name="citation_author_institution" content="CNRS, UMR_7210, Paris, France" /><meta name="citation_author_institution" content="Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France" /><meta name="citation_author_institution" content="Ambroise Par&#x000e9; Hospital, APHP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France" /><meta name="citation_publication_date" content="2011" /><meta name="citation_volume" content="17" /><meta name="citation_firstpage" content="745" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3062522/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3062522/" /><meta name="citation_pmid" content="21437201" /><meta name="DC.Title" content="Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Emory University" /><meta name="DC.Contributor" content="A. Pauly" /><meta name="DC.Contributor" content="E. Brasnu" /><meta name="DC.Contributor" content="L. Riancho" /><meta name="DC.Contributor" content="F. Brignole-Baudouin" /><meta name="DC.Contributor" content="C. Baudouin" /><meta name="DC.Date" content="2011" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model" /><meta property="og:type" content="article" /><meta property="og:description" content="To compare the effects of benzalkonium chloride (BAC)-preserved and unpreserved antiallergic eye drops on the human 3D-reconstituted corneal epithelial model (3D-HCE).3D-HCE were treated for 24 h followed or not by a 24 h post-incubation recovery period ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062522/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3062522/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/533/">Mol Vis</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/193179/">v.17; 2011</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3062522
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3062522/pdf/mv-v17-745.pdf" class="int-view">PDF (1.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3062522/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3062522/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3062522" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="uiyJ7nREYZctXvT2mPAcxMeV6ijOLmRmwcoIM4eHZ9hbDIFc7QiDd4xteH06fhS5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F&amp;text=Multiple%20endpoint%20analysis%20of%20BAC-preserved%20and%20unpreserved%20antiallergic%20eye%20drops%20on%20a%203D-reconstituted%20corneal%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062522/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/21437201/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/21437201/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3062522/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/533/">Mol Vis</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/193179/">v.17; 2011</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3062522
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-molvis.gif" alt="Logo of molvis" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.molvis.org/molvis/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Mol Vis.</span> 2011; 17: 745–755. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2011 Mar 16. </span>  </div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3062522</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21437201">21437201</a></div></div></div><h1 class="content-title">Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pauly%20A%5BAuthor%5D" class="affpopup" co-rid="_co_idm139842677702144" co-class="co-affbox">A. Pauly</a>,<sup>1,</sup><sup>2,</sup><sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brasnu%20E%5BAuthor%5D" class="affpopup" co-rid="_co_idm139842674599440" co-class="co-affbox">E. Brasnu</a>,<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Riancho%20L%5BAuthor%5D" class="affpopup" co-rid="_co_idm139842677330720" co-class="co-affbox">L. Riancho</a>,<sup>1,</sup><sup>2,</sup><sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brignole-Baudouin%20F%5BAuthor%5D" class="affpopup" co-rid="_co_idm139842670840528" co-class="co-affbox">F. Brignole-Baudouin</a>,<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>5</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Baudouin%20C%5BAuthor%5D" class="affpopup" co-rid="_co_idm139842677699792" co-class="co-affbox">C. Baudouin</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>6</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139842677702144"><h3 class="no_margin">A. Pauly</h3><p><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</p><p><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</p><p><sup>3</sup>CNRS, UMR_7210, Paris, France</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pauly%20A%5BAuthor%5D">A. Pauly</a></div></div><div id="_co_idm139842674599440"><h3 class="no_margin">E. Brasnu</h3><p><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</p><p><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</p><p><sup>3</sup>CNRS, UMR_7210, Paris, France</p><p><sup>4</sup>Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brasnu%20E%5BAuthor%5D">E. Brasnu</a></div></div><div id="_co_idm139842677330720"><h3 class="no_margin">L. Riancho</h3><p><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</p><p><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</p><p><sup>3</sup>CNRS, UMR_7210, Paris, France</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Riancho%20L%5BAuthor%5D">L. Riancho</a></div></div><div id="_co_idm139842670840528"><h3 class="no_margin">F. Brignole-Baudouin</h3><p><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</p><p><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</p><p><sup>3</sup>CNRS, UMR_7210, Paris, France</p><p><sup>5</sup>Department of Toxicology, Faculty of Biological and Pharmacological Sciences, Paris, France</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Brignole-Baudouin%20F%5BAuthor%5D">F. Brignole-Baudouin</a></div></div><div id="_co_idm139842677699792"><h3 class="no_margin">C. Baudouin</h3><p><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</p><p><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</p><p><sup>3</sup>CNRS, UMR_7210, Paris, France</p><p><sup>4</sup>Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France</p><p><sup>6</sup>Ambroise Par&#x000e9; Hospital, APHP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Baudouin%20C%5BAuthor%5D">C. Baudouin</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139842678307344_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139842678307344_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139842678307344_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139842678307344_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>1</sup>INSERM, UMR_S968, Institut de la Vision, Paris, France</div><div class="fm-affl" id="aff2"><sup>2</sup>UPMC University Paris 06, UMR_S 968, Institut de la Vision, Paris, France</div><div class="fm-affl" id="aff3"><sup>3</sup>CNRS, UMR_7210, Paris, France</div><div class="fm-affl" id="aff4"><sup>4</sup>Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Paris, France</div><div class="fm-affl" id="aff5"><sup>5</sup>Department of Toxicology, Faculty of Biological and Pharmacological Sciences, Paris, France</div><div class="fm-affl" id="aff6"><sup>6</sup>Ambroise Par&#x000e9; Hospital, APHP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="fn-a.i.b.f.a">The first two authors contributed equally to this work</div><div id="cor1">Correspondence to: Pr Christophe Baudouin, Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, 28, rue de Charenton, 75012, Paris, France&#x000a0;; Phone: +33.1.40.02.13.01; FAX: +33.1.40.02.13.99&#x000a0;; email: <a href="mailto:dev@null" data-email="rf.stgniv-ezniuq@niuoduabc" class="oemail">rf.stgniv-ezniuq@niuoduabc</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm139842678307344_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2011 Feb 1; Accepted 2011 Mar 10.</div></div><div class="permissions half_rhythm hide" id="idm139842678307344_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2011 Molecular Vision.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.i.b.n" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.ntitle">Abstract</h2><!--article-meta--><div><div id="sec-a.i.b.n.a" class="sec sec-first"><h3 id="sec-a.i.b.n.atitle">Purpose</h3><p class="p p-first-last">To compare the effects of benzalkonium chloride (BAC)-preserved and unpreserved antiallergic eye drops on the human 3D-reconstituted corneal epithelial model (3D-HCE).</p></div><div id="sec-a.i.b.n.b" class="sec"><h3 id="sec-a.i.b.n.btitle">Methods</h3><p class="p p-first-last">3D-HCE were treated for 24 h followed or not by a 24 h post-incubation recovery period (24 h+24 h) with phosphate-buffered saline (PBS), 0.01% BAC, unpreserved formulations of ketotifen, N Acetyl-Aspartyl Glutamic Acid (NAAGA), cromoglycate, or BAC-preserved commercial formulations of ketotifen, olopatadine, epinastine, and levocabastine. The 3D-HCE viability was evaluated using the 3-(4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium Bromide (MTT) test at 24 h and 24 h+24 h. At 24 h, the numbers of Cluster of Differentiation 54 (CD54)- and Ki67-immunopositive cells as well as the number of apoptotic deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL)-positive cells were evaluated on 3D-HCE frozen sections. The expression of the tight junction-associated protein occludin was also assessed using fluorescence confocal microscopy on flat-mounted 3D-HCE epithelia.</p></div><div id="sec-a.i.b.n.c" class="sec"><h3 id="sec-a.i.b.n.ctitle">Results</h3><p class="p p-first-last">The MTT and the TUNEL tests revealed a significant decrease of cell viability and an increased apoptosis in the superficial layers of the 3D-HCE only when treated with BAC-containing formulations and in a BAC concentration-dependent manner. The expression of CD54 and Ki67 in the basal layers was also increased in this group. A concentration-dependent disorganization of occludin distribution in the epithelium treated with BAC-containing solutions was also observed. The unpreserved formulations induced effects comparable to the control.</p></div><div id="sec-a.i.b.n.d" class="sec sec-last"><h3 id="sec-a.i.b.n.dtitle">Conclusions</h3><p class="p p-first-last">BAC-preserved solutions decreased cell viability and induced apoptosis in a concentration-dependent manner. Moreover, they induced CD54 expression, proliferation in the basal layers, and changes in the distribution of occludin, which is consistent with a disorganization of the tight-junctions and suggests the loss of the epithelial barrier function. On the contrary, the unpreserved solutions did not impair cell structures and viability, suggesting a better tolerance for the ocular surface. As allergic patients often exhibit impaired and inflammatory ocular surface, BAC-free compounds should be the first choice when treating allergic conjunctivitis.</p></div></div></div><div id="sec-a.j.a" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.j.atitle">Introduction</h2><p class="p p-first">To limit and counteract the clinical manifestations of allergic diseases, antiallergic compounds can be used. One of these molecules, ketotifen fumarate, has demonstrated both H1-receptor antagonism and mast cell stabilizing properties while inhibiting chemotaxis and eosinophil activation [<a href="#r1" rid="r1" class=" bibr popnode">1</a>,<a href="#r2" rid="r2" class=" bibr popnode">2</a>]. Moreover, ketotifen fumarate was shown to be well tolerated and effective in reducing the signs and symptoms of allergic conjunctivitis [<a href="#r3" rid="r3" class=" bibr popnode">3</a>-<a href="#r6" rid="r6" class=" bibr popnode">6</a>]. Allergic conjunctivitis, however, has often a tendency to become chronic, due to repeated allergic challenge or progressive impairment of the tear film and ocular surface [<a href="#r7" rid="r7" class=" bibr popnode">7</a>,<a href="#r8" rid="r8" class=" bibr popnode">8</a>].</p><p>As preservatives are usually used to prevent multidose eyedrop microbial contamination, their chronic administration may cause further ocular surface changes, at the levels of tear film and conjunctiva. They can induce cytotoxic effects and deleterious reactions when used over long-term periods. Indeed, the mostly used preservative benzalkonium chloride (BAC) was already shown to exhibit toxic and inflammatory effects in clinical, in vivo and in vitro studies [<a href="#r9" rid="r9" class=" bibr popnode">9</a>-<a href="#r20" rid="r20" class=" bibr popnode">20</a>]. Chronic use of BAC in eye drops is known to be responsible for apoptosis and oxidative stress on conjunctival cells, and to induce conjunctival inflammation that has demonstrated potentially harmful effects on glaucoma outcome, e.g., on glaucoma surgery efficacy [<a href="#r17" rid="r17" class=" bibr popnode">17</a>,<a href="#r21" rid="r21" class=" bibr popnode">21</a>-<a href="#r25" rid="r25" class=" bibr popnode">25</a>].</p><p>In this context, the implementation of very sensitive tools to predict eye tolerance is critical for ophthalmologists, who may be faced with long-term induced toxicity of substances used at low concentration in ophthalmic preparations. Supplied by SkinEthic<sup>&#x000ae;</sup> Laboratories (Nice, France), the reconstructed three-dimensional (3D) model of human corneal cells (3D-HCE) is an appropriate model for pre-screening or investigating the undesirable effects of ophthalmic drugs. It constitutes an interesting alternative to animal testing that is time-consuming and often invasive and may lack suited sensitive tools able to detect subclinical reactions [<a href="#r26" rid="r26" class=" bibr popnode">26</a>-<a href="#r28" rid="r28" class=" bibr popnode">28</a>]. Multi-endpoint analyses using adapted and improved techniques on such 3D-models have already proved efficacy for the assessment of BAC toxicity [<a href="#r28" rid="r28" class=" bibr popnode">28</a>] and eyedrop tolerance [<a href="#r27" rid="r27" class=" bibr popnode">27</a>].</p><p class="p p-last">The objective of this study was to investigate a large range of commonly used antiallergic eye drops in this 3D-HCE system and compare the tissue changes after treatment with BAC-preserved commercial formulations of ketotifen, olopatadine, epinastine or levocabastine, and unpreserved commercial formulations of ketotifen, N Acetyl-Aspartyl Glutamic Acid (NAAGA), or cromoglycate. Particularly, our purpose was to determine the involvement of BAC in epithelial cell damage induced after treatment with BAC-preserved and unpreserved antiallergic eyedrops.</p></div><div id="sec-a.j.b" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.j.btitle">Methods</h2><div id="sec-a.j.b.b" class="sec sec-first"><h3 id="sec-a.j.b.btitle">Tissue model and antiallergic solution treatments</h3><p class="p p-first">The 3D-HCE model (SkinEthic<sup>&#x000ae;</sup> Laboratories, Nice, France) consists of immortalized HCE cells grown vertically on a 0.5 cm<sup>2</sup> insert permeable polycarbonate filter. All the experiments were conducted as published previously [<a href="#r27" rid="r27" class=" bibr popnode">27</a>-<a href="#r29" rid="r29" class=" bibr popnode">29</a>]. Thirty microliters of each solution were applied on the apical surface of 3D-HCEs for 24 h and 24 h followed by 24 h additional recovery time: sterile phosphate-buffered saline (PBS) used as negative control solution, BAC solutions at 0.01% used as positive control, the commercial solutions of 0.01% BAC-containing ketotifen fumarate 0.025% (Zaditen<sup>&#x000ae;</sup>; Novartis Pharma SAS, Rueil-Malmaison, France), 0.01% BAC-containing olopatadine chlorhydrate 0.1% (Opatanol<sup>&#x000ae;</sup>; Patanol<sup>&#x000ae;</sup>; Alcon, Ft. Worth, TX), 0.01% BAC-containing epinastine chlorhydrate 0.05% (Purivist<sup>&#x000ae;</sup>; Allergan, Irvine, CA), 0.015% BAC-containing levocabastine chlorhydrate 0.05% (Levophta<sup>&#x000ae;</sup>; Chauvin Bausch &#x00026; Lomb, Montpellier, France), preservative-free ketotifen fumarate 0.025% (Zalerg<sup>&#x000ae;</sup>; Thea, Clermont-Ferrand, France), preservative-free NAAGA 4.9% (NAABAK<sup>&#x000ae;</sup>; Thea) and preservative-free sodium cromoglycate 2% (Cromabak<sup>&#x000ae;</sup>; Thea; <a href="/pmc/articles/PMC3062522/table/t1/" target="table" class="fig-table-link figpopup" rid-figpopup="t1" rid-ob="ob-t1" co-legend-rid=""><span>Table 1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="t1"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Benzalkonium chloride (BAC) and active compound content of the antiallergic eye drops tested.</strong></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><strong>Eye drops</strong></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><strong>Active compound content</strong></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><strong>BAC content</strong></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ketotifen fumarate (Zaditen&#x000ae;; Novartis Pharma SAS,Rueil-Malmaison, France)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.025%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.01%<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Olopatadine chlorhydrate (Opatanol&#x000ae;; Patanol&#x000ae;; Alcon, Ft. Worth, TX)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.1%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.01%<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Epinastine chlorhydrate (Purivist&#x000ae;; Allergan, Irvin, CA)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.05%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.01%<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Levocabastine chlorhydrate (Levophta&#x000ae;; Chauvin Bausch &#x00026; Lomb, Montpellier, France)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.05%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.015%<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Preservative-free ketotifen fumarate (Zalerg&#x000ae;; Thea, Clermont-Ferrand, France)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">0.025%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Preservative-free NAAGA (NAABAK&#x000ae;; Thea, Clermont-Ferrand, France)<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">4.9%<hr /></td><td valign="top" align="center" rowspan="1" colspan="1">-<hr /></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Preservative-free sodium cromoglycate (Cromabak&#x000ae;; Thea, Clermont-Ferrand, France)</td><td valign="top" align="center" rowspan="1" colspan="1">2%</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm139842714577600"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/table/t1/?report=objectonly">Open in a separate window</a></div></div><p class="p p-last">The recovery period (24 h) was chosen to assess the potential reversibility of toxic effects on 3D-HCE. Six series of 3D-HCE were used for each solution: two series for cell viability 3-(4,5-Dimethylthiazol-2-yl) -2,5-Diphenyltetrazolium Bromide (MTT) testing, two series for histomorphologic analyses after hematoxylin and eosin staining and immunohistological analyses on cryosections, and two series for immunofluorescent labeling on the most superficial layers of 3D-HCE by en-face confocal microscopic analyses.</p></div><div id="sec-a.j.b.c" class="sec"><h3 id="sec-a.j.b.ctitle">Modified MTT test</h3><p class="p p-first-last">The modified MTT test was used to assess cellular viability as described previously [<a href="#r27" rid="r27" class=" bibr popnode">27</a>-<a href="#r29" rid="r29" class=" bibr popnode">29</a>]. Experiments were conducted in duplicate. The 3D-HCEs were transferred in 24-well plates containing 300&#x000a0;&#x003bc;l of the MTT solution diluted at 0.5&#x000a0;mg/ml in culture medium and 300&#x000a0;&#x000b5;l of the same MTT solution were applied on the apical surface of the 3D-HCEs. Reconstituted tissues were incubated for 3 h. Then, the 3D-HCEs were transferred into 24-well plates containing 750&#x000a0;&#x000b5;l isopropanol, and 750&#x000a0;&#x000b5;l isopropanol were added to the apical surface of the 3D-HCEs. After a 2-h agitation, solutions were vigorously homogenized before reading the absorbance at 570 nm versus 690 nm. Results were expressed as a percentage of cell viability compared to the negative control, PBS. Analyses were performed using Safire technology (Tecan, Lyon, France).</p></div><div id="sec-a.j.b.d" class="sec"><h3 id="sec-a.j.b.dtitle">Confocal immunofluorescence analyses on cryosections and entire epithelia</h3><p class="p p-first-last">After incubation with the 9 different solutions, the 3D-HCE samples were transferred into Petri dishes containing PBS to be separated into two pieces using a surgical scalpel. Each piece of tissue was embedded in OCT<sup>&#x000ae;</sup> medium (Tissue-Tek, Miles Inc., Elkhart, IN), and frozen at &#x02013;80&#x000a0;&#x000b0;C. Vertical cryosections (10&#x000a0;&#x003bc;m thick) were then cut using a cryotome (Leica CM 3050s, Leica Microsystems AG, Wetzlar, Germany). The cryosections were fixed in 4% paraformaldehyde (PFA) for 20 min before immunofluorescent labeling of the tight junction protein occludin.</p></div><div id="sec-a.j.b.e" class="sec"><h3 id="sec-a.j.b.etitle">Detection of apoptosis (TUNEL assay), inflammation (CD54) and proliferation (Ki67) on 3D-HCE cryosections</h3><div id="sec-a.j.b.e.b" class="sec sec-first"><p></p><h4 id="sec-a.j.b.e.btitle" class="inline">Apoptosis, TUNEL assay </h4><p class="p p-first-last">Apoptosis in the tissue layers was detected using a terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) kit containing TUNEL enzyme and TUNEL label (Roche Diagnostics, Meylan, France). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) and the cryosections were mounted in an anti-fade medium (Vectashield; Vector Laboratories, Burlingame, CA).</p></div><div id="sec-a.j.b.e.c" class="sec"><p></p><h4 id="sec-a.j.b.e.ctitle" class="inline">CD54 (ICAM-1) and Ki67 immunostaining </h4><p class="p p-first-last">First, samples were fixed with 4% PFA for 10 min. Then, samples were permeabilized with 0.01%-diluted Triton X100<sup>&#x000ae;</sup> (Sigma Chemical Company, St. Louis, MO) for 5 min. Cells were incubated in presence of the mouse anti-human cluster of differentiation 54 (CD54) (IgG1; 1:100 final dilution; BD Biosciences, PharMingen, San Diego, CA), the mouse anti-human Ki67 (1:25 final dilution; Immunotech, Marseilles, France) or with the isotypic control mouse IgG1 (BD Biosciences) primary antibodies. Alexa 488 conjugated-goat anti-mouse IgG (Invitrogen-Molecular Probes, Eugene, OR) was used as second antibody at a 1:500 dilution. Nuclei were labeled with propidium iodide (PI) and cryosections were mounted in Vectashield. Samples were analyzed under a laser confocal microscope equipped with a digital camera (E800; PCM 2000; Nikon, Champigny-sur-Marne, France). Immunopositive cells were then counted under the 20&#x000d7; objective of the microscope in three different areas. Results were calculated as the average of counts, and finally expressed as cell numbers per mm of epithelial length (mm.E.L.) after each treatment.</p></div><div id="sec-a.j.b.e.d" class="sec sec-last"><p></p><h4 id="sec-a.j.b.e.dtitle" class="inline">Confocal immunofluorescence on entire epithelia for tight junction staining </h4><p class="p p-first-last">The rabbit anti-human occludin (IgG1; 1:100 dilution; Dako, Glostrup, Denmark) was used for tight junction staining. Alexa 488-conjugated goat anti-rabbit was used as second antibody. Samples were then analyzed under a laser confocal microscope (E800; PCM 2000; Nikon) for detecting occludin expression.</p></div></div><div id="sec-a.j.b.f" class="sec sec-last"><h3 id="sec-a.j.b.ftitle">Quantification and statistical analysis</h3><p class="p p-first-last">Quantification of TUNEL-, ICAM-1-, and Ki67-positive cells was performed manually, using a microscopic grid on images under 400&#x000d7; magnification. Results were expressed as mean cell numbers per millimeter of epithelial length (mm.E.L). Standard deviations were indicated. Statistical comparisons were performed using two-way analysis of variance (ANOVA), followed by multiple pairwise comparisons using the Fisher&#x02019;s adjustment (Statview V for Windows; SAS Institute, Cary, NC).</p></div></div><div id="sec-a.j.c" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.j.ctitle">Results</h2><div id="sec-a.j.c.b" class="sec sec-first"><h3 id="sec-a.j.c.btitle">Cell viability: MTT test</h3><p class="p p-first">The PBS negative control did not affect the cell viability neither at 24 h nor after the 24 h-recovery period (24 h+24 h; <a href="/pmc/articles/PMC3062522/figure/f1/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1" rid-ob="ob-f1" co-legend-rid="lgnd_f1"><span>Figure 1</span></a>). The unpreserved formulation of ketotifen fumarate KETO-BAC(-) showed the same level of cell viability as PBS at 24 h (99,4%) and a slight decrease of viability after 24 h+24 h (86.9% of the control). The preservative-free formulations of NAAGA and cromoglycate, NAA-BAC(-) and CRO-BAC(-), also showed a weak decrease of cellular viability at 24 h (93.2% and 95.1%, respectively) and after 24 h+24 h (87.7% for both; <a href="/pmc/articles/PMC3062522/figure/f1/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1" rid-ob="ob-f1" co-legend-rid="lgnd_f1"><span>Figure 1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f1" co-legend-rid="lgnd_f1"><a href="/pmc/articles/PMC3062522/figure/f1/" target="figure" rid-figpopup="f1" rid-ob="ob-f1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139842671285264"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3062522_mv-v17-745-f1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mv-v17-745-f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3062522/bin/mv-v17-745-f1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139842671285264"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/figure/f1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f1"><div><a class="figpopup" href="/pmc/articles/PMC3062522/figure/f1/" target="figure" rid-figpopup="f1" rid-ob="ob-f1">Figure 1</a></div><!--caption a7--><div class="caption"><p>Cell viability MTT test. Cellular viability of 3D-HCEs treated with PBS, 0.01% BAC, NAA-BAC(-), CRO-BAC(-), KETO-BAC(-), KETO-BAC(+), OPA-BAC(+), EPI-BAC(+), or LEVO-BAC(+) for 24 h followed or not by a 24 h post-incubation period (24 h+24 h-recovery). BAC induced a concentration-dependent decrease of cellular viability. At 24 h, the unpreserved NAA-BAC(-), CRO-BAC(-), and KETO-BAC(-) formulations induced a slight or insignificant decrease of cellular viability, while the KETO-BAC (+), OPA-BAC(+), EPI-BAC(+), and LEVO-BAC(+) BAC-containing formulations induced a marked decrease of cellular viability compared to control. After the 24-h recovery period, the unpreserved formulations showed a weak additional decrease of cellular viability, while the BAC-containing formulations still induced a strong decrease of cellular viability compared to control, showing irreversible damage to 3D-HCE. Results are expressed as percentage of cell viability compared to the PBS control.</p></div></div></div><p class="p p-last">Conversely, as expected according to previous studies [<a href="#r28" rid="r28" class=" bibr popnode">28</a>], 0.01% BAC showed a significant decrease of cell viability at 24 h and after 24 h+24 h (59.6% and 55% viability, respectively). Cell viability decreased in a BAC-concentration dependant manner for the BAC-containing antiallergic formulations, with a highest toxicity observed with the 0.015% BAC-containing levocabastine chlorhydrate 0.05% [LEVO-BAC(+)]. Cell viability levels were 66.8% at 24 h and 55.3% at 24 h+24 h for 0.01% BAC-containing ketotifen fumarate 0.025% [KETO-BAC(+)], 63.7% at 24 h and 60.5% at 24 h+24 h for 0.01% BAC-containing olopatadine chlorhydrate 0.1% [OPA-BAC(+)], 52.1% at 24 h and 56.6% at 24 h+24 h for 0.01% BAC-containing epinastine chlorhydrate 0.05% [EPI-BAC(+)], and 46.3% at 24 h and 44.3% at 24 h+24 h for LEVO-BAC(+).</p></div><div id="sec-a.j.c.c" class="sec"><h3 id="sec-a.j.c.ctitle">Immunofluorescence analyses and quantification of apoptosis (TUNEL)</h3><p class="p p-first">Few apoptotic cells were observed after PBS incubation (6.4 cells/mm.E.L.). Similar levels of apoptosis were observed with the 3 unpreserved antiallergic formulations (<a href="/pmc/articles/PMC3062522/figure/f2/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2" rid-ob="ob-f2" co-legend-rid="lgnd_f2"><span>Figure 2</span></a>): 9.2 cells/mm.E.L. for NAA-BAC(-), 12.2 cells/mm.E.L. for CRO-BAC(-), and 8.6 cells/mm.E.L. for KETO-BAC(-), without any statistically significant difference compared to PBS.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f2" co-legend-rid="lgnd_f2"><a href="/pmc/articles/PMC3062522/figure/f2/" target="figure" rid-figpopup="f2" rid-ob="ob-f2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139842678777856"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3062522_mv-v17-745-f2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mv-v17-745-f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3062522/bin/mv-v17-745-f2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139842678777856"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/figure/f2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f2"><div><a class="figpopup" href="/pmc/articles/PMC3062522/figure/f2/" target="figure" rid-figpopup="f2" rid-ob="ob-f2">Figure 2</a></div><!--caption a7--><div class="caption"><p>Apoptosis analysis (TUNEL). Localization of TUNEL positive cells (green) on 3D-HCE samples after 24 h of incubation with PBS (<strong>A</strong>), 0.01% BAC (<strong>B</strong>), KETO-BAC(-) (<strong>C</strong>), KETO-BAC(+) (<strong>D</strong>), NAA-BAC(-) (<strong>E</strong>), OPA-BAC(+) (<strong>F</strong>), CRO-BAC(-) (<strong>G</strong>), EPI-BAC(+) (<strong>H</strong>), LEVO-BAC(+) (<strong>I</strong>). Nuclei were stained with DAPI (blue). No or very rare apoptotic cells were observed after PBS (<strong>A</strong>), KETO-BAC(-) (<strong>C</strong>), KETO-BAC(+) (<strong>D</strong>) and NAA-BAC(-) (<strong>E</strong>) treatments. KETO-BAC(+) (<strong>D</strong>) and OPA-BAC(+) (<strong>F</strong>) induced moderate expression of apoptosis, and 0.01% BAC (<strong>B</strong>), EPI-BAC(+) (<strong>H</strong>) and LEVO-BAC(+) (<strong>I</strong>) induced a greater number of TUNEL-positive cells principally in the apical cell layers, and also in the middle epithelial layers with EPI-BAC(+) (<strong>H</strong>) and LEVO-BAC(+) (<strong>I</strong>). Deeper modifications were observed with 0.015% BAC-containing LEVO-BAC(+) (<strong>I</strong>) compared to 0.01% BAC (<strong>B</strong>), with a greater number of TUNEL-positive cells in the middle epithelial layers and a higher level of vacuolization in the basal epithelial layers observed with LEVO-BAC(+) (<strong>I</strong>). The quantification of apoptotic cells with the TUNEL assay (<strong>J</strong>) showed that apoptotic cell number increased in a BAC concentration-dependent manner. BAC at 0.01% and the four BAC-containing formulations KETO-BAC(+), OPA-BAC(+), EPI-BAC(+) and LEVO-BAC(+) showed much higher expression of apoptotic TUNEL-positive cells than did the unpreserved formulations NAA-BAC(-), CRO-BAC(-), KETO-BAC(-) at 24 h. Results are expressed as cell number per mm of epithelial length (mm.E.L.): Mean&#x000b1;SD *Statistically significant compared to PBS with p&#x0003c;0.0014. **Statistically significant compared to 0.01% BAC with p&#x0003c;0.0014. &#x02020;Statistically significant compared to EPI-BAC(+) with p&#x0003c;0.0014. $Statistically significant compared to LEVO-BAC(+) with p&#x0003c;0.0014.</p></div></div></div><p class="p p-last">Consistent with previously published reports with the same technique [<a href="#r28" rid="r28" class=" bibr popnode">28</a>,<a href="#r29" rid="r29" class=" bibr popnode">29</a>], BAC at 0.01% significantly increased the number of TUNEL-positive cells compared to PBS (p&#x0003c;0.0014). Apoptosis also increased on cells treated with all BAC-containing antiallergic formulations, with a statistically significant difference compared to PBS (p&#x0003c;0.0014): 28, 29.3, 46.6, and 75.5 cells/mm.E.L. for KETO-BAC(+), OPA-BAC(+), EPI-BAC(+), and LEVO-BAC(+), respectively.</p></div><div id="sec-a.j.c.d" class="sec"><h3 id="sec-a.j.c.dtitle">Immunofluorescence analyses and quantification of the inflammation marker ICAM-1 (CD54)</h3><p class="p p-first">CD54 expression was measured at 70 cells/mm.E.L. on PBS-treated 3D-HCE cultures (<a href="/pmc/articles/PMC3062522/figure/f3/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3" rid-ob="ob-f3" co-legend-rid="lgnd_f3"><span>Figure 3</span></a>). The three unpreserved antiallergic formulations NAA-BAC(-), CRO-BAC(-), and KETO-BAC(-) expressed CD54 at low levels too, respectively, 60.3, 59.3, and 64 cells/mm.E.L., with no statistically significant differences compared to PBS. Conversely, 0.01% BAC and LEVO-BAC(+) showed increased levels of CD54 expression with a statistically significant difference compared to PBS (p&#x0003c;0.001): 150.4 cells/mm.E.L. for 0.01% BAC and 142 cells/mm.E.L. for LEVO-BAC(+). KETO-BAC(+), OPA-BAC(+), EPI-BAC(+) showed increased levels of CD54 expression too, but no statistically significant difference was found neither with PBS nor with 0.01% BAC i.e., 98.5, 114 and 92 cells/mm.E.L. for KETO-BAC(+), OPA-BAC(+) and EPI-BAC(+), respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f3" co-legend-rid="lgnd_f3"><a href="/pmc/articles/PMC3062522/figure/f3/" target="figure" rid-figpopup="f3" rid-ob="ob-f3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139842714017568"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3062522_mv-v17-745-f3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mv-v17-745-f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3062522/bin/mv-v17-745-f3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139842714017568"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/figure/f3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f3"><div><a class="figpopup" href="/pmc/articles/PMC3062522/figure/f3/" target="figure" rid-figpopup="f3" rid-ob="ob-f3">Figure 3</a></div><!--caption a7--><div class="caption"><p>Inflammation analysis. Immunolocalization of CD54 (ICAM-1) positive cells (green) on 3D-HCE samples after 24 h of incubation with PBS (<strong>A</strong>), 0.01% BAC (<strong>B</strong>), KETO-BAC(-) (<strong>C</strong>), KETO-BAC(+) (<strong>D</strong>), NAA-BAC(-) (<strong>E</strong>), OPA-BAC(+) (<strong>F</strong>), CRO-BAC(-) (<strong>G</strong>), EPI-BAC(+) (<strong>H</strong>), LEVO-BAC(+) (<strong>I</strong>). Nuclei were stained with propidium iodide (PI, red). PBS (<strong>A</strong>), KETO-BAC(-) (<strong>C</strong>), NAA-BAC(-) (<strong>E</strong>) and CRO-BAC(-) (<strong>G</strong>) showed a weak expression of CD54. A significant increase of CD54 expression was observed after the treatments with 0.01% BAC (<strong>B</strong>) and LEVO-BAC(+) (<strong>I</strong>), showing a green staining in all the epithelial layers. LEVO-BAC(+) (<strong>I</strong>) showed deeper modifications with a higher loss of continuity between cells and a higher level of vacuolization observed in the basal epithelial layers. KETO-BAC(+) (<strong>D</strong>), OPA-BAC(+) (<strong>F</strong>) and EPI-BAC(+) (<strong>H</strong>) showed an intermediate CD54 expression that was localized in all epithelial layers. Quantification of CD54-positive cells (<strong>J</strong>) showed a higher CD54 expression with BAC at 0.01% or the four BAC-containing formulations KETO-BAC(+), OPA-BAC(+), EPI-BAC(+) and LEVO-BAC(+) than with the unpreserved formulations NAA-BAC(-), CRO-BAC(-), KETO-BAC(-) at 24 h. *Statistically significant compared to PBS with p&#x0003c;0.001. **Statistically significant compared to 0.01% BAC with p&#x0003c;0.001. Results are expressed as cell number per mm of epithelial length (mm.E.L.): Mean&#x000b1;SD.</p></div></div></div></div><div id="sec-a.j.c.e" class="sec"><h3 id="sec-a.j.c.etitle">Immunofluorescence analyses of cell proliferation marker Ki67</h3><p class="p p-first">After PBS treatment (<a href="/pmc/articles/PMC3062522/figure/f4/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4" rid-ob="ob-f4" co-legend-rid="lgnd_f4"><span>Figure 4</span></a>), few proliferating cells were observed (29.2 cells/mm.E.L), scattered throughout the entire epithelium. Similar findings were observed with the unpreserved antiallergic treatments, with no statistically significant differences compared to PBS: 28.3, 30.0, and 27.3 cells/mm.E.L. for NAA-BAC(-), CRO-BAC(-), and KETO-BAC(-), respectively (<a href="/pmc/articles/PMC3062522/figure/f4/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4" rid-ob="ob-f4" co-legend-rid="lgnd_f4"><span>Figure 4</span></a>). Conversely, numerous proliferating cells, with a greater number located in the basal layer, were found after 0.01% BAC, KETO-BAC(+), OPA-BAC(+), and EPI-BAC(+) with a statistically significant difference (p&#x0003c;0.04) compared to PBS: 55.3, 45, 45, and 55 cells/mm.E.L., respectively. With LEVO-BAC(+), no proliferative cells were observed, most likely due to the deep impairment of corneal cells as this group showed the most important number of apoptotic cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f4" co-legend-rid="lgnd_f4"><a href="/pmc/articles/PMC3062522/figure/f4/" target="figure" rid-figpopup="f4" rid-ob="ob-f4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139842714003632"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3062522_mv-v17-745-f4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mv-v17-745-f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3062522/bin/mv-v17-745-f4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139842714003632"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/figure/f4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f4"><div><a class="figpopup" href="/pmc/articles/PMC3062522/figure/f4/" target="figure" rid-figpopup="f4" rid-ob="ob-f4">Figure 4</a></div><!--caption a7--><div class="caption"><p>Proliferation analysis. Immunolocalization of Ki67 positive cells (green) on 3D-HCE samples after 24h of incubation with PBS (<strong>A</strong>), 0.01% BAC (<strong>B</strong>), KETO-BAC(-) (<strong>C</strong>), KETO-BAC(+) (<strong>D</strong>), NAA-BAC(-) (<strong>E</strong>), OPA-BAC(+) (<strong>F</strong>), CRO-BAC(-) (<strong>G</strong>), EPI-BAC(+) (<strong>H</strong>), LEVO-BAC(+) (<strong>I</strong>). Nuclei were stained with propidium iodide (PI, red). PBS (<strong>A</strong>), KETO-BAC(-) (<strong>C</strong>), NAA-BAC(-) (<strong>E</strong>) and CRO-BAC(-) (<strong>G</strong>) showed a weak expression of Ki67 in all epithelial layers. BAC at 0.01% (<strong>B</strong>), KETO-BAC(+) (<strong>D</strong>), OPA-BAC(+) (<strong>F</strong>), and EPI-BAC(+) (<strong>H</strong>) showed a higher Ki67 expression in all epithelial layers too. With LEVO-BAC(+), no Ki67 positive cells were observed, most likely due to the deep impairment of corneal cells with a most likely inhibition of proliferative capabilities of 3D-HCE submitted at this higher concentration in BAC. Quantification of Ki67-positive cells was concordant with these observations (<strong>J</strong>). *Statistically significant compared to PBS with p&#x0003c;0.04. **Statistically significant compared to 0.01% BAC with p&#x0003c;0.001. $Statistically significant compared to the other solutions tested. Results are expressed as cell number per mm of epithelial length (mm.E.L.): Mean&#x000b1;SD.</p></div></div></div></div><div id="sec-a.j.c.f" class="sec sec-last"><h3 id="sec-a.j.c.ftitle">En-face confocal microscopic analysis of the tight junction-associated protein occludin</h3><p class="p p-first">En-face confocal microscopic analysis of 3D-HCE cultures treated with PBS, NAA-BAC(-), CRO-BAC(-), and KETO-BAC(-) revealed a fine membrane immunostaining of occludin in large superficial cells, forming a ring around the cells (<a href="/pmc/articles/PMC3062522/figure/f5/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5" rid-ob="ob-f5" co-legend-rid="lgnd_f5"><span>Figure 5</span></a>). This kind of occludin expression clearly disappeared after treatment with either 0.01% BAC, KETO-BAC(+), OPA-BAC(+), EPI-BAC(+), or LEVO-BAC(+), all showing damaged cells with non-specific staining.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f5" co-legend-rid="lgnd_f5"><a href="/pmc/articles/PMC3062522/figure/f5/" target="figure" rid-figpopup="f5" rid-ob="ob-f5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139842711992464"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3062522_mv-v17-745-f5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is mv-v17-745-f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3062522/bin/mv-v17-745-f5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139842711992464"><a target="object" rel="noopener" href="/pmc/articles/PMC3062522/figure/f5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f5"><div><a class="figpopup" href="/pmc/articles/PMC3062522/figure/f5/" target="figure" rid-figpopup="f5" rid-ob="ob-f5">Figure 5</a></div><!--caption a7--><div class="caption"><p>Tight junction-associated protein occludin. Immunofluorescence analysis of occludin expressions using en-face confocal microscopy after treatment with PBS (<strong>A</strong>), 0.01% BAC (<strong>B</strong>), NAA-BAC(-) (<strong>C</strong>) CRO-BAC(-) (<strong>D</strong>), KETO-BAC(-) (<strong>E</strong>), KETO-BAC(+) (<strong>F</strong>), OPA-BAC(+) (<strong>G</strong>), EPI-BAC(+) (<strong>H</strong>), LEVO-BAC(+) (<strong>I</strong>). Bar=100 &#x000b5;m.</p></div></div></div></div></div><div id="sec-a.j.d" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.j.dtitle">Discussion</h2><p class="p p-first">In this study, the toxicological model of 3D-reconstructed cornea was very helpful to demonstrate the effects of BAC-preserved solutions on corneal cells in vitro, showing increased apoptosis, CD54 expression, proliferation in the basal layers and changes in the distribution of occludin induced with BAC-containing antiallergic treatments. On the contrary, the unpreserved ketotifen, NAAGA and cromoglycate solutions did not impair cell structures and viability, suggesting a better tolerance for the ocular surface.</p><p>The highly differentiated, three-dimensional epithelial system of human ocular origin is a desirable model for pre-screening or investigating the effects of ophthalmic drugs. It frees the experimenter from interspecies differences and allows a better approach to the ocular epithelial physiology than monolayer models and cells originating from other organs. It also constitutes an interesting alternative to animal testing, respecting the ethical guidelines of animal experimentation, especially the 3R rule (refining, reducing and replacing the use of animals) [<a href="#r30" rid="r30" class=" bibr popnode">30</a>,<a href="#r31" rid="r31" class=" bibr popnode">31</a>]. The reconstructed three dimensional (3D) model of human corneal cells (3D-HCE), supplied by SkinEthic<sup>&#x000ae;</sup> Laboratories, was found to resemble the corneal epithelium of the human eye in morphology and thickness [<a href="#r32" rid="r32" class=" bibr popnode">32</a>]. Such a 3D-system models is not only useful to demonstrate the different effects of toxic substances on specific cell types, but also shows the interactions between the cells and the spatial effects induced by the toxic. Moreover, epithelium cultures at the air-liquid interface are easy-to-handle and facilitate in vivo-like product exposures. The 3D-HCEs were found to express cytokeratin-3 and include hemidesmosomes within the basal layers. Furthermore, they can inhibit the flow of ionic material such as Na-fluorescein across their surface [<a href="#r32" rid="r32" class=" bibr popnode">32</a>,<a href="#r33" rid="r33" class=" bibr popnode">33</a>], suggesting the presence of a functional epithelial barrier. Different types of intercellular junctions have been identified in the corneal epithelium ex vivo. Among them, adherens junctions, comprising the E-cadherin protein, serve to anchor cells together [<a href="#r34" rid="r34" class=" bibr popnode">34</a>]. Also, the tight-junctions, originally defined as zonula occludentes (ZO) and comprising occludin, ZO-1 and other proteins, are thought to provide the hydrophobic barrier preventing the free passage of molecules between adjacent epithelial cells [<a href="#r35" rid="r35" class=" bibr popnode">35</a>-<a href="#r37" rid="r37" class=" bibr popnode">37</a>]. In a previous study [<a href="#r28" rid="r28" class=" bibr popnode">28</a>], we developed a new procedure of the classical MTT test used on 3D-reconstituted epidermal and corneal models to evaluate the viability. This procedure showed increased sensitivity levels and allowed detecting slight damage even in the most superficial layers. Therefore, it is well suited to the prediction of low to very low irritant potential, especially when products are used repeatedly during long-term periods of time, like in allergic conjunctivitis, when repeated allergenic challenge or ocular surface impairment occur and require sustained therapy.</p><p>Although the morphological relevance and sensitivity of the 3D-HCE model allowed the modeling of cumulative effects that may approach conditions obtained after long-term application of eye-drops [<a href="#r27" rid="r27" class=" bibr popnode">27</a>], our in vitro findings cannot fully be extrapolated to in vivo conditions. Indeed, preserved eye drops may be less toxic in vivo, according to the continuous action of the eyelids, the permanent renewal of ocular surface epithelia, and the presence of the preocular mucin layer and glycocalyx. Conversely, the accumulation of BAC-containing eye drops in the eye and the long-term use of eye drops in allergic patients with ocular surface disorders will emphasize the risk of toxic reactions and further contribute to inflammatory stimulation throughout the ocular surface, at least at a subclinical level [<a href="#r38" rid="r38" class=" bibr popnode">38</a>].</p><p>In the present study, using our modified MTT procedure, we evaluated the effects of either preserved or unpreserved antiallergic formulations on cellular viability and correlated these results with those of a TUNEL assay performed on 3D-HCE frozen sections. Then, we investigated on entire 3D-HCE and using en-face confocal microscopy the changes of expression and spatial distribution of cellular markers involved in intercellular junctions such as occludin after the different antiallergic treatments.</p><p>Thus, with this procedure, we were able to demonstrate concentration-dependent cytotoxic effects of BAC at 24 h, the absence of significant cellular viability decrease following treatment with the ketotifen, NAAGA and cromoglycate BAC-free formulations, and a cell viability decrease similar to that disclosed by the 0.01% BAC treatment with the BAC-containing antiallergic formulations of ketotifen, olopatadine, epinastine and levocabastatine. We confirmed the toxic and proinflammatory effects of the BAC-containing solutions using a TUNEL assay and CD54 immunostaining performed on 3D-HCE frozen sections and found a significantly increased number of apoptotic cells and an increased CD54 expression following exposure to 0.01% BAC and BAC-containing solutions compared to the control. Finally, we examined the integrity of the structural and functional barrier conferred by the tight-junctions by assessing the distribution pattern of the occludin protein. The tight-junctions regulate the passive movement of fluids, electrolytes, macromolecules and cells through the paracellular pathway, thereby contributing to the corneal defense system and to the maintenance of the corneal homeostasis. In the mouse cornea, the occludin distribution pattern was already described as altered by a detergent treatment (Triton X100) using immunohistochemistry [<a href="#r39" rid="r39" class=" bibr popnode">39</a>]. In a previous study, Chuan et al. [<a href="#r40" rid="r40" class=" bibr popnode">40</a>] showed the effects of contact lens multipurpose solutions on the corneal cells&#x02019; barrier function using fluorescein permeability assay and immunofluorescent staining for tight junctions proteins (ZO-1 and occludin). Recently, we also demonstrated that occludin mRNA expression was correlated to BAC early toxic effects [<a href="#r28" rid="r28" class=" bibr popnode">28</a>]. Our results were consistent with those studies, showing the disturbance of occludin tight-junction protein distribution after BAC-containing antiallergic treatments.</p><p>Currently, allergic conjunctivitis incidence is increasing in developed countries. According to Manners T et al. [<a href="#r41" rid="r41" class=" bibr popnode">41</a>], 15% of eye related consultations in general practice are due to allergic conjunctivitis. Recommended topical treatments for symptoms of allergic conjunctivitis include topical mast cell stabilizers and/or topical antihistamines (H1-receptor antagonists). Some of the new antiallergic drugs now available may have both effects and sometimes additional properties, such as the ability to inhibit the expression of cell adhesion molecules (CAMs) on the cell surface or to attenuate inflammatory mediator release [<a href="#r1" rid="r1" class=" bibr popnode">1</a>,<a href="#r3" rid="r3" class=" bibr popnode">3</a>-<a href="#r6" rid="r6" class=" bibr popnode">6</a>,<a href="#r42" rid="r42" class=" bibr popnode">42</a>-<a href="#r45" rid="r45" class=" bibr popnode">45</a>].</p><p>The panel of eye drops tested in the present study was deemed to be fairly representative of the predominantly prescribed therapeutic antiallergic molecules at the time of these experiments in France. Indeed, among the commercial antiallergic eye drops, one can distinguish between two types of formulations, according to the presence of BAC as preservative. Currently, the antihistamines olopatadine, epinastine and levocabastine are available only as preserved solutions whereas ketotifen is recently accessible in both formulations. These four antihistamines constitute a group of comparable products from the therapeutic use viewpoint and all of them are available as preserved solutions. We deemed it interesting to add the preservative-free ketotifen solution in the comparison. Naaga and cromoglycate eye drops belong to a different class of antiallergic agents, i.e., the mast cells degranulation inhibitors. Although they were both available as preserved and unpreserved formulations, we chose to only test their unpreserved formulations in order not to weigh the experiment down all the more since the preserved eye drop forms of these two molecules are now much less used in therapeutics than their unpreserved counterparts. Overall, our panel choice was conducted by the actuality of the antiallergic armamentarium that is available to the patients.</p><p>There is currently enough evidence from clinical, in vivo, and in vitro studies that long-term use of preserved topical drugs may induce several deleterious effects on ocular surface, being responsible for ocular discomfort, tear film instability, conjunctival inflammation, subconjunctival fibrosis and epithelial apoptosis [<a href="#r9" rid="r9" class=" bibr popnode">9</a>]. Several studies have confirmed the participation of high concentrations of BAC-preserved eye drops in induction of ocular surface inflammation, allergy, fibrosis, punctate corneal staining, and dry eye syndrome [<a href="#r9" rid="r9" class=" bibr popnode">9</a>,<a href="#r38" rid="r38" class=" bibr popnode">38</a>,<a href="#r46" rid="r46" class=" bibr popnode">46</a>,<a href="#r47" rid="r47" class=" bibr popnode">47</a>]. Three mechanisms have been described: detergent effects inducing loss of tear film stability; immunoallergic reactions; and direct toxic effects to epithelial cells [<a href="#r48" rid="r48" class=" bibr popnode">48</a>,<a href="#r49" rid="r49" class=" bibr popnode">49</a>]. Other experimental and clinical studies have shown that the long-term use of BAC-containing ophthalmic solutions can induce conjunctival stroma infiltrates and overexpression of inflammation- or apoptosis-related molecules, such as class II antigen HLADR, ICAM-1, Fas antigen, or the apoptotic marker Apo 2.7 [<a href="#r50" rid="r50" class=" bibr popnode">50</a>-<a href="#r52" rid="r52" class=" bibr popnode">52</a>].</p><p>In the present study, we showed that BAC-containing eye antiallergic solutions may decrease cell viability, induce apoptosis, ICAM-1 expression and proliferation in the basal layers, and changes in the distribution of occludin. Conversely, the unpreserved ketotifen, NAAGA and cromoglycate formulations did not impair cell structures and viability, suggesting a better tolerance for the ocular surface. These findings were consistent with several previous in vitro or ex vivo studies that demonstrated BAC toxicity and potential advantages of BAC-free formulations [<a href="#r9" rid="r9" class=" bibr popnode">9</a>]. Moreover, the present results support our earlier findings on antiallergic preserved and unpreserved eye-drops. Indeed, in a previous study, we showed that antiallergic eye drops preserved with BAC induced high ICAM-1 expression levels, apoptosis and oxidative stress and reduced cellular viability in opposition to the unpreserved formulations of NAAGA and cromoglycate [<a href="#r53" rid="r53" class=" bibr popnode">53</a>].</p><p>In addition, our results were consistent with a recent study by Ayaki et al. [<a href="#r54" rid="r54" class=" bibr popnode">54</a>] on corneal and conjunctival cell lines that showed that cell toxicity was mostly affected by the concentration of BAC rather than the active component of antiallergic ophthalmic solutions. The use of a large range of commonly antiallergic eye drops in the present study was useful to support this point, showing BAC-concentration dependent toxic effects in all experiments. This may emphasize the fact that epithelial toxicity was most likely induced by the preservative (BAC) than by the active antiallergic compound in the present study too.</p><p class="p p-last">These findings strongly support the use of preservative-free solutions in patients with chronic eye diseases and treatments over the long-term, especially in allergic conjunctivitis or dry eye conditions. Definitely, preservative-free antiallergic medications may decrease the adverse effects of chronic topical medications, which could lead to better tolerability, lower treatment discontinuations and improved quality of life of patients with ocular allergic diseases.</p></div><div id="ack-a.k.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.k.atitle">Acknowledgments</h2><div class="sec"><p>The study was supported by an unrestricted grant from Th&#x000e9;a (Clermont-Ferrand, France).</p></div></div><div id="ref-list-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.k.btitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="r1">1. <span class="element-citation">Mart&#x000ed;n AP, Urrets-Zavalia J, Berra A, Mariani AL, Gallino N, Gomez Demel E, Gagliardi J, Baena-Cagnani CE, Urrets-Zavalia E, Serra HM. The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study. <span><span class="ref-journal">BMC Ophthalmol. </span>2003;<span class="ref-vol">3</span>:2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC140320/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12515585" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Ophthalmol&amp;title=The+effect+of+ketotifen+on+inflammatory+markers+in+allergic+conjunctivitis:+an+open,+uncontrolled+study.&amp;author=AP+Mart&#x000ed;n&amp;author=J+Urrets-Zavalia&amp;author=A+Berra&amp;author=AL+Mariani&amp;author=N+Gallino&amp;volume=3&amp;publication_year=2003&amp;pages=2&amp;pmid=12515585&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r2">2. <span class="element-citation">Schoch C. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis. <span><span class="ref-journal">J Ocul Pharmacol Ther. </span>2003;<span class="ref-vol">19</span>:153–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12804060" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Ocul+Pharmacol+Ther&amp;title=Effects+of+ketotifen+0.025%+and+lodoxamide+0.1%+on+eosinophil+infiltration+into+the+guinea+pig+conjunctiva+in+a+model+of+allergic+conjunctivitis.&amp;author=C+Schoch&amp;volume=19&amp;publication_year=2003&amp;pages=153-9&amp;pmid=12804060&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r3">3. <span class="element-citation">Borazan M, Karalezli A, Akova YA, Akman A, Kiyici H, Erbek SS. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. <span><span class="ref-journal">Acta Ophthalmol. </span>2009;<span class="ref-vol">87</span>:549–54.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18631332" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Ophthalmol&amp;title=Efficacy+of+olopatadine+HCI+0.1%,+ketotifen+fumarate+0.025%,+epinastine+HCI+0.05%,+emedastine+0.05%+and+fluorometholone+acetate+0.1%+ophthalmic+solutions+for+seasonal+allergic+conjunctivitis:+a+placebo-controlled+environmental+trial.&amp;author=M+Borazan&amp;author=A+Karalezli&amp;author=YA+Akova&amp;author=A+Akman&amp;author=H+Kiyici&amp;volume=87&amp;publication_year=2009&amp;pages=549-54&amp;pmid=18631332&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r4">4. <span class="element-citation">Avunduk AM, Tekelioglu Y, Turk A, Akyol N. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. <span><span class="ref-journal">Clin Ther. </span>2005;<span class="ref-vol">27</span>:1392–402.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16291412" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Ther&amp;title=Comparison+of+the+effects+of+ketotifen+fumarate+0.025%+and+olopatadine+HCl+0.1%+ophthalmic+solutions+in+seasonal+allergic+conjunctivities:+a+30-day,+randomized,+double-masked,+artificial+tear+substitute-controlled+trial.&amp;author=AM+Avunduk&amp;author=Y+Tekelioglu&amp;author=A+Turk&amp;author=N+Akyol&amp;volume=27&amp;publication_year=2005&amp;pages=1392-402&amp;pmid=16291412&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r5">5. <span class="element-citation">Kidd M, McKenzie SH, Steven I, Cooper C, Lanz R. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis. <span><span class="ref-journal">Br J Ophthalmol. </span>2003;<span class="ref-vol">87</span>:1206–11.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1920791/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14507747" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Efficacy+and+safety+of+ketotifen+eye+drops+in+the+treatment+of+seasonal+allergic+conjunctivitis.&amp;author=M+Kidd&amp;author=SH+McKenzie&amp;author=I+Steven&amp;author=C+Cooper&amp;author=R+Lanz&amp;volume=87&amp;publication_year=2003&amp;pages=1206-11&amp;pmid=14507747&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r6">6. <span class="element-citation">Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. <span><span class="ref-journal">Adv Ther. </span>2003;<span class="ref-vol">20</span>:79–91.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12836808" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+Ther&amp;title=Ketotifen+fumarate+and+olopatadine+hydrochloride+in+the+treatment+of+allergic+conjunctivitis:+a+real-world+comparison+of+efficacy+and+ocular+comfort.&amp;author=M+Ganz&amp;author=E+Koll&amp;author=J+Gausche&amp;author=P+Detjen&amp;author=N+Orfan&amp;volume=20&amp;publication_year=2003&amp;pages=79-91&amp;pmid=12836808&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r7">7. <span class="element-citation">Bielory L, Friedlaender MH. Allergic conjunctivitis. <span><span class="ref-journal">Immunol Allergy Clin North Am. </span>2008;<span class="ref-vol">28</span>:43–58.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18282545" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Allergy+Clin+North+Am&amp;title=Allergic+conjunctivitis.&amp;author=L+Bielory&amp;author=MH+Friedlaender&amp;volume=28&amp;publication_year=2008&amp;pages=43-58&amp;pmid=18282545&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r8">8. <span class="element-citation">Wong AH, Barg SS, Leung AK. Seasonal and perennial allergic conjunctivitis. <span><span class="ref-journal">Recent Pat Inflamm Allergy Drug Discov. </span>2009;<span class="ref-vol">3</span>:118–27.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19519588" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Recent+Pat+Inflamm+Allergy+Drug+Discov&amp;title=Seasonal+and+perennial+allergic+conjunctivitis.&amp;author=AH+Wong&amp;author=SS+Barg&amp;author=AK+Leung&amp;volume=3&amp;publication_year=2009&amp;pages=118-27&amp;pmid=19519588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r9">9. <span class="element-citation">Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. <span><span class="ref-journal">Prog Retin Eye Res. </span>2010;<span class="ref-vol">29</span>:312–34.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20302969" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Retin+Eye+Res&amp;title=Preservatives+in+eyedrops:+the+good,+the+bad+and+the+ugly.&amp;author=C+Baudouin&amp;author=A+Labbe&amp;author=H+Liang&amp;author=A+Pauly&amp;author=F+Brignole-Baudouin&amp;volume=29&amp;publication_year=2010&amp;pages=312-34&amp;pmid=20302969&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r10">10. <span class="element-citation">Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. <span><span class="ref-journal">Ophthalmology. </span>2008;<span class="ref-vol">115</span>:109–15.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17532048" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=The+ocular+surface+of+glaucoma+patients+treated+over+the+long+term+expresses+inflammatory+markers+related+to+both+T-helper+1+and+T-helper+2+pathways.&amp;author=C+Baudouin&amp;author=H+Liang&amp;author=P+Hamard&amp;author=L+Riancho&amp;author=C+Creuzot-Garcher&amp;volume=115&amp;publication_year=2008&amp;pages=109-15&amp;pmid=17532048&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r11">11. <span class="element-citation">Brasnu E, Brignole-Baudouin F, Riancho L, Guenoun JM, Warnet JM, Baudouin C. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. <span><span class="ref-journal">Curr Eye Res. </span>2008;<span class="ref-vol">33</span>:303–12.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18398704" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Eye+Res&amp;title=In+vitro+effects+of+preservative-free+tafluprost+and+preserved+latanoprost,+travoprost,+and+bimatoprost+in+a+conjunctival+epithelial+cell+line.&amp;author=E+Brasnu&amp;author=F+Brignole-Baudouin&amp;author=L+Riancho&amp;author=JM+Guenoun&amp;author=JM+Warnet&amp;volume=33&amp;publication_year=2008&amp;pages=303-12&amp;pmid=18398704&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r12">12. <span class="element-citation">Baudouin C, Riancho L, Warnet JM, Brignole F. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2007;<span class="ref-vol">48</span>:4123–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17724196" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=In+vitro+studies+of+antiglaucomatous+prostaglandin+analogues:+travoprost+with+and+without+benzalkonium+chloride+and+preserved+latanoprost.&amp;author=C+Baudouin&amp;author=L+Riancho&amp;author=JM+Warnet&amp;author=F+Brignole&amp;volume=48&amp;publication_year=2007&amp;pages=4123-8&amp;pmid=17724196&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r13">13. <span class="element-citation">Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. <span><span class="ref-journal">Br J Ophthalmol. </span>2008;<span class="ref-vol">92</span>:1275–82.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2569147/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18723745" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Conjunctival+and+corneal+reactions+in+rabbits+following+short-+and+repeated+exposure+to+preservative-free+tafluprost,+commercially+available+latanoprost+and+0.02%+benzalkonium+chloride.&amp;author=H+Liang&amp;author=C+Baudouin&amp;author=A+Pauly&amp;author=F+Brignole-Baudouin&amp;volume=92&amp;publication_year=2008&amp;pages=1275-82&amp;pmid=18723745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r14">14. <span class="element-citation">Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM, Brignole-Baudouin F. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:2444–50.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15980234" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=In+vitro+study+of+inflammatory+potential+and+toxicity+profile+of+latanoprost,+travoprost,+and+bimatoprost+in+conjunctiva-derived+epithelial+cells.&amp;author=JM+Guenoun&amp;author=C+Baudouin&amp;author=P+Rat&amp;author=A+Pauly&amp;author=JM+Warnet&amp;volume=46&amp;publication_year=2005&amp;pages=2444-50&amp;pmid=15980234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r15">15. <span class="element-citation">Ichijima H, Petroll WM, Jester JV, Cavanagh HD. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. <span><span class="ref-journal">Cornea. </span>1992;<span class="ref-vol">11</span>:221–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1587129" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cornea&amp;title=Confocal+microscopic+studies+of+living+rabbit+cornea+treated+with+benzalkonium+chloride.&amp;author=H+Ichijima&amp;author=WM+Petroll&amp;author=JV+Jester&amp;author=HD+Cavanagh&amp;volume=11&amp;publication_year=1992&amp;pages=221-5&amp;pmid=1587129&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r16">16. <span class="element-citation">Ishibashi T, Yokoi N, Kinoshita S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. <span><span class="ref-journal">J Glaucoma. </span>2003;<span class="ref-vol">12</span>:486–90.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14646684" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Glaucoma&amp;title=Comparison+of+the+short-term+effects+on+the+human+corneal+surface+of+topical+timolol+maleate+with+and+without+benzalkonium+chloride.&amp;author=T+Ishibashi&amp;author=N+Yokoi&amp;author=S+Kinoshita&amp;volume=12&amp;publication_year=2003&amp;pages=486-90&amp;pmid=14646684&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r17">17. <span class="element-citation">Buron N, Micheau O, Cathelin S, Lafontaine PO, Creuzot-Garcher C, Solary E. Differential mechanisms of conjunctival cell death induction by ultraviolet irradiation and benzalkonium chloride. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2006;<span class="ref-vol">47</span>:4221–30.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17003409" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Differential+mechanisms+of+conjunctival+cell+death+induction+by+ultraviolet+irradiation+and+benzalkonium+chloride.&amp;author=N+Buron&amp;author=O+Micheau&amp;author=S+Cathelin&amp;author=PO+Lafontaine&amp;author=C+Creuzot-Garcher&amp;volume=47&amp;publication_year=2006&amp;pages=4221-30&amp;pmid=17003409&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r18">18. <span class="element-citation">Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. <span><span class="ref-journal">J Ocul Pharmacol Ther. </span>2009;<span class="ref-vol">25</span>:113–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2958436/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19284328" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Ocul+Pharmacol+Ther&amp;title=Comparative+toxicity+of+preservatives+on+immortalized+corneal+and+conjunctival+epithelial+cells.&amp;author=SP+Epstein&amp;author=M+Ahdoot&amp;author=E+Marcus&amp;author=PA+Asbell&amp;volume=25&amp;publication_year=2009&amp;pages=113-9&amp;pmid=19284328&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r19">19. <span class="element-citation">Martone G, Frezzotti P, Tosi GM, Traversi C, Mittica V, Malandrini A, Pichierri P, Balestrazzi A, Motolese PA, Motolese I, Motolese E. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. <span><span class="ref-journal">Am J Ophthalmol. </span>2009;<span class="ref-vol">147</span>:725–35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19181302" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Ophthalmol&amp;title=An+in+vivo+confocal+microscopy+analysis+of+effects+of+topical+antiglaucoma+therapy+with+preservative+on+corneal+innervation+and+morphology.&amp;author=G+Martone&amp;author=P+Frezzotti&amp;author=GM+Tosi&amp;author=C+Traversi&amp;author=V+Mittica&amp;volume=147&amp;publication_year=2009&amp;pages=725-35&amp;pmid=19181302&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r20">20. <span class="mixed-citation">Rolando M, Brezzo V, Giordano G, Campagna P, Burlando S, Calabria G. The effect of different benzalkonium chloride concentrations on human normal ocular surface. In: Van Bijsterveld O, Lemp M, Spinelli D, editors. The Lacrimal System. Amsterdam, Berkely, Milano: Kugler and Ghedini Publications; 1991. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Rolando+M,+Brezzo+V,+Giordano+G,+Campagna+P,+Burlando+S,+Calabria+G.+The+effect+of+different+benzalkonium+chloride+concentrations+on+human+normal+ocular+surface.+In:+Van+Bijsterveld+O,+Lemp+M,+Spinelli+D,+editors.+The+Lacrimal+System.+Amsterdam,+Berkely,+Milano:+Kugler+and+Ghedini+Publications;+1991.+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r21">21. <span class="element-citation">Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. <span><span class="ref-journal">Ophthalmology. </span>2004;<span class="ref-vol">111</span>:2186–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15582072" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Conjunctival+epithelial+cell+expression+of+interleukins+and+inflammatory+markers+in+glaucoma+patients+treated+over+the+long+term.&amp;author=C+Baudouin&amp;author=P+Hamard&amp;author=H+Liang&amp;author=C+Creuzot-Garcher&amp;author=L+Bensoussan&amp;volume=111&amp;publication_year=2004&amp;pages=2186-92&amp;pmid=15582072&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r22">22. <span class="element-citation">Calonge M, Diebold Y, Saez V, Enriquez de Salamanca A, Garcia-Vazquez C, Corrales RM, Herreras JM. Impression cytology of the ocular surface: a review. <span><span class="ref-journal">Exp Eye Res. </span>2004;<span class="ref-vol">78</span>:457–72.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15106925" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;title=Impression+cytology+of+the+ocular+surface:+a+review.&amp;author=M+Calonge&amp;author=Y+Diebold&amp;author=V+Saez&amp;author=A+Enriquez+de+Salamanca&amp;author=C+Garcia-Vazquez&amp;volume=78&amp;publication_year=2004&amp;pages=457-72&amp;pmid=15106925&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r23">23. <span class="element-citation">Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. <span><span class="ref-journal">Ophthalmology. </span>1992;<span class="ref-vol">99</span>:197–202.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1348114" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Foreshortening+of+the+inferior+conjunctival+fornix+associated+with+chronic+glaucoma+medications.&amp;author=IR+Schwab&amp;author=JV+Linberg&amp;author=VM+Gioia&amp;author=WH+Benson&amp;author=GM+Chao&amp;volume=99&amp;publication_year=1992&amp;pages=197-202&amp;pmid=1348114&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r24">24. <span class="element-citation">Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. <span><span class="ref-journal">Br J Ophthalmol. </span>1993;<span class="ref-vol">77</span>:590–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC513958/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8218059" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Adverse+effects+of+topical+antiglaucomatous+medications+on+the+conjunctiva.&amp;author=D+Broadway&amp;author=I+Grierson&amp;author=R+Hitchings&amp;volume=77&amp;publication_year=1993&amp;pages=590-6&amp;pmid=8218059&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r25">25. <span class="element-citation">Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. <span><span class="ref-journal">Arch Ophthalmol. </span>1994;<span class="ref-vol">112</span>:1446–54.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7980134" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol&amp;title=Adverse+effects+of+topical+antiglaucoma+medication.+II.+The+outcome+of+filtration+surgery.&amp;author=DC+Broadway&amp;author=I+Grierson&amp;author=C+O'Brien&amp;author=RA+Hitchings&amp;volume=112&amp;publication_year=1994&amp;pages=1446-54&amp;pmid=7980134&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r26">26. <span class="element-citation">Doucet O, Lanvin M, Thillou C, Linossier C, Pupat C, Merlin B, Zastrow L. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. <span><span class="ref-journal">Toxicol In Vitro. </span>2006;<span class="ref-vol">20</span>:499–512.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16243479" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+In+Vitro&amp;title=Reconstituted+human+corneal+epithelium:+a+new+alternative+to+the+Draize+eye+test+for+the+assessment+of+the+eye+irritation+potential+of+chemicals+and+cosmetic+products.&amp;author=O+Doucet&amp;author=M+Lanvin&amp;author=C+Thillou&amp;author=C+Linossier&amp;author=C+Pupat&amp;volume=20&amp;publication_year=2006&amp;pages=499-512&amp;pmid=16243479&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r27">27. <span class="element-citation">Meloni M, Pauly A, Servi BD, Varlet BL, Baudouin C. Occludin gene expression as an early in vitro sign for mild eye irritation assessment. <span><span class="ref-journal">Toxicol In Vitro. </span>2010;<span class="ref-vol">24</span>:276–85.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19729060" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+In+Vitro&amp;title=Occludin+gene+expression+as+an+early+in+vitro+sign+for+mild+eye+irritation+assessment.&amp;author=M+Meloni&amp;author=A+Pauly&amp;author=BD+Servi&amp;author=BL+Varlet&amp;author=C+Baudouin&amp;volume=24&amp;publication_year=2010&amp;pages=276-85&amp;pmid=19729060&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r28">28. <span class="element-citation">Pauly A, Meloni M, Brignole-Baudouin F, Warnet JM, Baudouin C. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2009;<span class="ref-vol">50</span>:1644–52.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19168896" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Multiple+endpoint+analysis+of+the+3D-reconstituted+corneal+epithelium+after+treatment+with+benzalkonium+chloride:+early+detection+of+toxic+damage.&amp;author=A+Pauly&amp;author=M+Meloni&amp;author=F+Brignole-Baudouin&amp;author=JM+Warnet&amp;author=C+Baudouin&amp;volume=50&amp;publication_year=2009&amp;pages=1644-52&amp;pmid=19168896&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r29">29. <span class="element-citation">Liang H, Pauly A, Riancho L, Baudouin C, Brignole-Baudouin F. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogs on a 3D-reconstituted corneal epithelium system. <span><span class="ref-journal">Br J Ophthalmol. </span>2010</span> In press . <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3099447/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21429894" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Toxicological+evaluation+of+preservative-containing+and+preservative-free+topical+prostaglandin+analogs+on+a+3D-reconstituted+corneal+epithelium+system.&amp;author=H+Liang&amp;author=A+Pauly&amp;author=L+Riancho&amp;author=C+Baudouin&amp;author=F+Brignole-Baudouin&amp;publication_year=2010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r30">30. <span class="element-citation">Manciocco A, Chiarotti F, Vitale A, Calamandrei G, Laviola G, Alleva E. The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson's disease. <span><span class="ref-journal">Neurosci Biobehav Rev. </span>2009;<span class="ref-vol">33</span>:18–32.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18771685" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurosci+Biobehav+Rev&amp;title=The+application+of+Russell+and+Burch+3R+principle+in+rodent+models+of+neurodegenerative+disease:+the+case+of+Parkinson's+disease.&amp;author=A+Manciocco&amp;author=F+Chiarotti&amp;author=A+Vitale&amp;author=G+Calamandrei&amp;author=G+Laviola&amp;volume=33&amp;publication_year=2009&amp;pages=18-32&amp;pmid=18771685&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r31">31. <span class="mixed-citation">ECVAM Technical Report on the Status of Alternative Methods for Cosmetics Testing (2008&#x02013;2009). A report prepared in the framework of Directive 2003/15/EC (7th Amendment to the Cosmetics Directive): Publications Office of the European Union; 2010.</span></div><div class="ref-cit-blk half_rhythm" id="r32">32. <span class="mixed-citation">Nguyen DH, Beuerman RW, De Wever B, Rosdy M. Alternative Toxicological Methods. Salem H, Katz S, Editors: CRC Press; 2003. p. 147&#x02013;59. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Nguyen+DH,+Beuerman+RW,+De+Wever+B,+Rosdy+M.+Alternative+Toxicological+Methods.+Salem+H,+Katz+S,+Editors:+CRC+Press;+2003.+p.+147&#x02013;59.+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r33">33. <span class="element-citation">Kahn CR, Young E, Lee IH, Rhim JS. Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>1993;<span class="ref-vol">34</span>:3429–41.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7693609" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Human+corneal+epithelial+primary+cultures+and+cell+lines+with+extended+life+span:+in+vitro+model+for+ocular+studies.&amp;author=CR+Kahn&amp;author=E+Young&amp;author=IH+Lee&amp;author=JS+Rhim&amp;volume=34&amp;publication_year=1993&amp;pages=3429-41&amp;pmid=7693609&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r34">34. <span class="element-citation">Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">84</span>:345–57.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8608588" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Cell+adhesion:+the+molecular+basis+of+tissue+architecture+and+morphogenesis.&amp;author=BM+Gumbiner&amp;volume=84&amp;publication_year=1996&amp;pages=345-57&amp;pmid=8608588&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r35">35. <span class="element-citation">Wang Y, Chen M, Wolosin JM. ZO-1 in corneal epithelium; stratal distribution and synthesis induction by outer cell removal. <span><span class="ref-journal">Exp Eye Res. </span>1993;<span class="ref-vol">57</span>:283–92.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8224016" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;title=ZO-1+in+corneal+epithelium;+stratal+distribution+and+synthesis+induction+by+outer+cell+removal.&amp;author=Y+Wang&amp;author=M+Chen&amp;author=JM+Wolosin&amp;volume=57&amp;publication_year=1993&amp;pages=283-92&amp;pmid=8224016&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r36">36. <span class="element-citation">Langbein L, Grund C, Kuhn C, Praetzel S, Kartenbeck J, Brandner JM, Moll I, Franke WW. Tight junctions and compositionally related junctional structures in mammalian stratified epithelia and cell cultures derived therefrom. <span><span class="ref-journal">Eur J Cell Biol. </span>2002;<span class="ref-vol">81</span>:419–35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12234014" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cell+Biol&amp;title=Tight+junctions+and+compositionally+related+junctional+structures+in+mammalian+stratified+epithelia+and+cell+cultures+derived+therefrom.&amp;author=L+Langbein&amp;author=C+Grund&amp;author=C+Kuhn&amp;author=S+Praetzel&amp;author=J+Kartenbeck&amp;volume=81&amp;publication_year=2002&amp;pages=419-35&amp;pmid=12234014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r37">37. <span class="element-citation">Ban Y, Dota A, Cooper LJ, Fullwood NJ, Nakamura T, Tsuzuki M, Mochida C, Kinoshita S. Tight junction-related protein expression and distribution in human corneal epithelium. <span><span class="ref-journal">Exp Eye Res. </span>2003;<span class="ref-vol">76</span>:663–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12742348" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;title=Tight+junction-related+protein+expression+and+distribution+in+human+corneal+epithelium.&amp;author=Y+Ban&amp;author=A+Dota&amp;author=LJ+Cooper&amp;author=NJ+Fullwood&amp;author=T+Nakamura&amp;volume=76&amp;publication_year=2003&amp;pages=663-9&amp;pmid=12742348&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r38">38. <span class="element-citation">Baudouin C. Allergic reaction to topical eyedrops. <span><span class="ref-journal">Curr Opin Allergy Clin Immunol. </span>2005;<span class="ref-vol">5</span>:459–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16131924" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Allergy+Clin+Immunol&amp;title=Allergic+reaction+to+topical+eyedrops.&amp;author=C+Baudouin&amp;volume=5&amp;publication_year=2005&amp;pages=459-63&amp;pmid=16131924&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r39">39. <span class="element-citation">Sosnov&#x000e1;-Netukov&#x000e1; M, Kuchynka P, Forrester JV. The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. <span><span class="ref-journal">Br J Ophthalmol. </span>2007;<span class="ref-vol">91</span>:372–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1857692/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17020902" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=The+suprabasal+layer+of+corneal+epithelial+cells+represents+the+major+barrier+site+to+the+passive+movement+of+small+molecules+and+trafficking+leukocytes.&amp;author=M+Sosnov&#x000e1;-Netukov&#x000e1;&amp;author=P+Kuchynka&amp;author=JV+Forrester&amp;volume=91&amp;publication_year=2007&amp;pages=372-8&amp;pmid=17020902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r40">40. <span class="element-citation">Chuang EY, Li DQ, Bian F, Zheng X, Pflugfelder SC. Effects of contact lens multipurpose solutions on human corneal epithelial survival and barrier function. <span><span class="ref-journal">Eye Contact Lens. </span>2008;<span class="ref-vol">34</span>:281–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8313347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18779668" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eye+Contact+Lens&amp;title=Effects+of+contact+lens+multipurpose+solutions+on+human+corneal+epithelial+survival+and+barrier+function.&amp;author=EY+Chuang&amp;author=DQ+Li&amp;author=F+Bian&amp;author=X+Zheng&amp;author=SC+Pflugfelder&amp;volume=34&amp;publication_year=2008&amp;pages=281-6&amp;pmid=18779668&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r41">41. <span class="element-citation">Manners T. Managing eye conditions in general practice. <span><span class="ref-journal">BMJ. </span>1997;<span class="ref-vol">315</span>:816–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2127522/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9345194" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Managing+eye+conditions+in+general+practice.&amp;author=T+Manners&amp;volume=315&amp;publication_year=1997&amp;pages=816-7&amp;pmid=9345194&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r42">42. <span class="element-citation">Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. <span><span class="ref-journal">Br J Gen Pract. </span>2004;<span class="ref-vol">54</span>:451–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1266207/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15186569" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Gen+Pract&amp;title=Topical+treatments+for+seasonal+allergic+conjunctivitis:+systematic+review+and+meta-analysis+of+efficacy+and+effectiveness.&amp;author=CG+Owen&amp;author=A+Shah&amp;author=K+Henshaw&amp;author=L+Smeeth&amp;author=A+Sheikh&amp;volume=54&amp;publication_year=2004&amp;pages=451-6&amp;pmid=15186569&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r43">43. <span class="element-citation">Abelson MB. A review of olopatadine for the treatment of ocular allergy. <span><span class="ref-journal">Expert Opin Pharmacother. </span>2004;<span class="ref-vol">5</span>:1979–94.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15330735" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Pharmacother&amp;title=A+review+of+olopatadine+for+the+treatment+of+ocular+allergy.&amp;author=MB+Abelson&amp;volume=5&amp;publication_year=2004&amp;pages=1979-94&amp;pmid=15330735&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r44">44. <span class="element-citation">Ciprandi G, Cosentino C, Milanese M, Tosca MA. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions. <span><span class="ref-journal">Ann Allergy Asthma Immunol. </span>2003;<span class="ref-vol">90</span>:434–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12722967" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Allergy+Asthma+Immunol&amp;title=Rapid+anti-inflammatory+action+of+azelastine+eyedrops+for+ongoing+allergic+reactions.&amp;author=G+Ciprandi&amp;author=C+Cosentino&amp;author=M+Milanese&amp;author=MA+Tosca&amp;volume=90&amp;publication_year=2003&amp;pages=434-8&amp;pmid=12722967&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r45">45. <span class="element-citation">Yanni JM, Weimer LK, Sharif NA, Xu SX, Gamache DA, Spellman JM. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. <span><span class="ref-journal">Arch Ophthalmol. </span>1999;<span class="ref-vol">117</span>:643–7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10326962" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol&amp;title=Inhibition+of+histamine-induced+human+conjunctival+epithelial+cell+responses+by+ocular+allergy+drugs.&amp;author=JM+Yanni&amp;author=LK+Weimer&amp;author=NA+Sharif&amp;author=SX+Xu&amp;author=DA+Gamache&amp;volume=117&amp;publication_year=1999&amp;pages=643-7&amp;pmid=10326962&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r46">46. <span class="element-citation">Fisher AA. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. <span><span class="ref-journal">Cutis. </span>1987;<span class="ref-vol">39</span>:381–3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3581909" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cutis&amp;title=Allergic+contact+dermatitis+and+conjunctivitis+from+benzalkonium+chloride.&amp;author=AA+Fisher&amp;volume=39&amp;publication_year=1987&amp;pages=381-3&amp;pmid=3581909&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r47">47. <span class="element-citation">Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. <span><span class="ref-journal">Ophthalmology. </span>1994;<span class="ref-vol">101</span>:454–60.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7907416" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Expression+of+inflammatory+membrane+markers+by+conjunctival+cells+in+chronically+treated+patients+with+glaucoma.&amp;author=C+Baudouin&amp;author=C+Garcher&amp;author=N+Haouat&amp;author=A+Bron&amp;author=P+Gastaud&amp;volume=101&amp;publication_year=1994&amp;pages=454-60&amp;pmid=7907416&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r48">48. <span class="element-citation">De Saint Jean M, Baudouin C, Di Nolfo M, Roman S, Lozato P, Warnet JM, Brignole F. Comparison of morphological and functional characteristics of primary-cultured human conjunctival epithelium and of Wong-Kilbourne derivative of Chang conjunctival cell line. <span><span class="ref-journal">Exp Eye Res. </span>2004;<span class="ref-vol">78</span>:257–74.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14729358" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Eye+Res&amp;title=Comparison+of+morphological+and+functional+characteristics+of+primary-cultured+human+conjunctival+epithelium+and+of+Wong-Kilbourne+derivative+of+Chang+conjunctival+cell+line.&amp;author=M+De+Saint+Jean&amp;author=C+Baudouin&amp;author=M+Di+Nolfo&amp;author=S+Roman&amp;author=P+Lozato&amp;volume=78&amp;publication_year=2004&amp;pages=257-74&amp;pmid=14729358&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r49">49. <span class="element-citation">Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P, Baudouin C. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2001;<span class="ref-vol">42</span>:642–52.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11222522" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Quaternary+ammoniums+and+other+preservatives'+contribution+in+oxidative+stress+and+apoptosis+on+Chang+conjunctival+cells.&amp;author=C+Debbasch&amp;author=F+Brignole&amp;author=PJ+Pisella&amp;author=JM+Warnet&amp;author=P+Rat&amp;volume=42&amp;publication_year=2001&amp;pages=642-52&amp;pmid=11222522&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r50">50. <span class="element-citation">Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud P, Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. <span><span class="ref-journal">Curr Eye Res. </span>1998;<span class="ref-vol">17</span>:419–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9561834" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Eye+Res&amp;title=Histopathological+effects+of+topical+ophthalmic+preservatives+on+rat+corneoconjunctival+surface.&amp;author=F+Becquet&amp;author=M+Goldschild&amp;author=MS+Moldovan&amp;author=M+Ettaiche&amp;author=P+Gastaud&amp;volume=17&amp;publication_year=1998&amp;pages=419-25&amp;pmid=9561834&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r51">51. <span class="element-citation">Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, Bechetoille A. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. <span><span class="ref-journal">Ophthalmology. </span>1999;<span class="ref-vol">106</span>:556–63.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10080214" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmology&amp;title=Ocular+surface+inflammatory+changes+induced+by+topical+antiglaucoma+drugs:+human+and+animal+studies.&amp;author=C+Baudouin&amp;author=PJ+Pisella&amp;author=K+Fillacier&amp;author=M+Goldschild&amp;author=F+Becquet&amp;volume=106&amp;publication_year=1999&amp;pages=556-63&amp;pmid=10080214&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r52">52. <span class="element-citation">Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>1994;<span class="ref-vol">232</span>:561–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7959096" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Graefes+Arch+Clin+Exp+Ophthalmol&amp;title=The+effect+of+preservatives+and+antiglaucomatous+medication+on+the+histopathology+of+the+conjunctiva.&amp;author=H+Mietz&amp;author=U+Niesen&amp;author=GK+Krieglstein&amp;volume=232&amp;publication_year=1994&amp;pages=561-5&amp;pmid=7959096&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r53">53. <span class="element-citation">Pauly A, Brignole-Baudouin F, Guenoun JM, Riancho L, Rat P, Warnet JM, Baudouin C. Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2007;<span class="ref-vol">245</span>:534–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16900358" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Graefes+Arch+Clin+Exp+Ophthalmol&amp;title=Comparative+study+of+topical+anti-allergic+eye+drops+on+human+conjunctiva-derived+cells:+responses+to+histamine+and+IFN+gamma+and+toxicological+profiles.&amp;author=A+Pauly&amp;author=F+Brignole-Baudouin&amp;author=JM+Guenoun&amp;author=L+Riancho&amp;author=P+Rat&amp;volume=245&amp;publication_year=2007&amp;pages=534-46&amp;pmid=16900358&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="r54">54. <span class="element-citation">Ayaki M, Iwasawa A, Yaguchi S, Koide R. Preserved and unpreserved 12 anti-allergic ophthalmic solutions and ocular surface toxicity: in vitro assessment in four cultured corneal and conjunctival epithelial cell lines. <span><span class="ref-journal">Biocontrol Sci. </span>2010;<span class="ref-vol">15</span>:143–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21212507" ref="reftype=pubmed&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biocontrol+Sci&amp;title=Preserved+and+unpreserved+12+anti-allergic+ophthalmic+solutions+and+ocular+surface+toxicity:+in+vitro+assessment+in+four+cultured+corneal+and+conjunctival+epithelial+cell+lines.&amp;author=M+Ayaki&amp;author=A+Iwasawa&amp;author=S+Yaguchi&amp;author=R+Koide&amp;volume=15&amp;publication_year=2010&amp;pages=143-8&amp;pmid=21212507&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3062522&amp;issue-id=193179&amp;journal-id=533&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Molecular Vision</span> are provided here courtesy of <strong>Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3062522/pdf/mv-v17-745.pdf" class="int-view">PDF (1.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3062522/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3062522/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3062522" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="uiyJ7nREYZctXvT2mPAcxMeV6ijOLmRmwcoIM4eHZ9hbDIFc7QiDd4xteH06fhS5">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F&amp;text=Multiple%20endpoint%20analysis%20of%20BAC-preserved%20and%20unpreserved%20antiallergic%20eye%20drops%20on%20a%203D-reconstituted%20corneal%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3062522%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062522/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/21437201/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/21437201/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3062522/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3062522/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3062522/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
